WEST PHARMACEUTICAL SERVICES INC WST 84.64
Health Care · NYSE · Data as of 2026-10-29
WEST PHARMACEUTICAL SERVICES INC (WST) has delivered +9.4% annualized revenue growth, +18.5% earnings growth, and +6.1% dividend growth over 10 years of data. Ranked #47 of 1968 stocks overall and #6 of 260 in the Health Care sector by Steady Score.
About WEST PHARMACEUTICAL SERVICES INC
Company Overview
West Pharmaceutical Services designs and manufactures components and delivery systems used with injectable medicines. Its proprietary products include elastomer stoppers, seals, syringe plungers, containment components and self-injection and drug-delivery systems. Pharmaceutical, biotechnology and generic-drug manufacturers use these products to protect medicines, maintain sterility and deliver accurate doses. West also contract-manufactures complex healthcare devices and components to individual customer specifications worldwide.
Read more
Business Model & Revenue
Revenue comes from sales of proprietary packaging and delivery products and from contract manufacturing. Proprietary products generate most sales and include standard and higher-value components with coatings, formulations or performance features, supported by development and testing services. Contract manufacturing earns revenue from producing customer-designed devices and assemblies. Demand follows injectable-drug production, customer inventory, regulatory approvals and the adoption of biologic and self-administered therapies.
Key Facts & Market Position
West operates two segments: Proprietary Products and Contract-Manufactured Products. Its components directly contact or help deliver medicines, so material science, cleanliness, manufacturing consistency and regulatory documentation are central to the customer relationship. Biologics are the largest market group for sales, while generic and other pharmaceutical customers use many of the same containment platforms.